Aims & Scope
Metabolic Syndrome and Related Disorders is the only peer-reviewed journal focusing solely on the pathophysiology, recognition, and treatment of this major health condition. The Journal meets the imperative for comprehensive research, data, and commentary on metabolic disorder as a suspected precursor to a wide range of diseases, including type 2 diabetes, cardiovascular disease, stroke, cancer, polycystic ovary syndrome, gout, and asthma.
Metabolic Syndrome and Related Disorders coverage includes:
- Insulin resistance
- Central obesity
- Glucose intolerance
- Dyslipidemia with elevated triglycerides
- Low HDL-cholesterol
- Predominance of small dense LDL-cholesterol particles
- Endothelial dysfunction
- Oxidative stress
- Related disorders of polycystic ovarian syndrome, fatty liver disease (NASH), and gout
Metabolic Syndrome and Related Disorders is under the editorial leadership of Editor-in-Chief Adrian Vella, MD, Mayo Clinic College of Medicine, MN, and other key investigators. View the entire editorial board.
Audience: Endocrinologists, metabolism researchers, and diabetes researchers, among others
Science Citation Index Expanded;
Journal Citation Reports/Science Edition;